Abscess formation is a classic host response to infection by many pathogenic microorganisms. Here, we studied the role of prostaglandins (PGs) and their signal transduction in abscess formation. Zymosan was injected into the pleural cavity of rats. Expression of enzymes involved in PG synthesis, their receptors, and cytokines in exudate leukocytes and abscesses were analyzed by polymerase chain reaction, Western blotting, and immunohistochemistry. Treatment with ketorolac, a cyclooxygenase (COX)-1 inhibitor, or N- [2-cyclohexyloxy-4-nitrophenyl] methanesulfonamide (NS-398), a COX-2 inhibitor, reduced the size of abscesses and the number of cells recovered from the abscess. COX-2 was detected in leukocytes of the exudate and a marginal area of abscesses. Among detected terminal PG synthases, the major one was cytosolic PGE synthase. Membrane-bound PGE synthase (mPGES)-1 was detected in cells that were similar to the COX-2-expressing cells in morphology and localization. A high level of the E-prostanoid (EP) 2 receptor and a low level of the EP 4 receptor were detected. The expression pattern of the EP 2 receptor paralleled that of COX-2 and mPGES-1. 11,15-O-Dimethyl PGE 2 (ONO-AE1-259), an EP 2 receptor agonist, and rolipram, a phosphodiesterase type-4 inhibitor, reversed the effects of COX inhibitors on abscess formation. In contrast, 16-(3-methoxymethyl) phenyl--tetranor-3,7-dithia PGE 1 (ONO-AE1-329), an EP 4 receptor agonist, did not reverse the effects of NS-398. Moreover, NS-398 reduced the mRNA levels in exudate leukocytes of some proinflammatory and fibrogenic cytokines, which was reversed by ONO-AE1-259. These results suggest that PGE 2 generated via COX-1 and COX-2 may interact with the EP 2 receptor and may up-regulate in cAMP-dependent fashion the production of cytokines that promote abscess formation.
PGI 2 , and TXA 2 (Simmons et al., 2004) . The genes encoding the terminal synthases involved in conversion of PGH 2 to each of the prostanoids, including PGD, PGE, PGF, PGI, and TX synthases (PGDS, PGES, PGFS, PGIS, and TXS, respectively), have been cloned and characterized. Two PGDS isoforms, hematopoietic PGDS (hPGDS) and lipocalin-type PGDS, and three distinct PGES isoforms, cytosolic PGES (cPGES), membrane-bound PGES (mPGES)-1, and mPGES-2, have been identified (Helliwell et al., 2004) .
Prostanoids exert their effects via specific cell surface, G protein-linked receptors. Prostanoid receptors have been classified into five types on the basis of their sensitivity to the primary prostanoids and have been termed DP, EP, FP, IP, and TP receptors, respectively (Narumiya et al., 1999) . Two DP receptor subtypes, DP 1 and DP 2 receptors, have been identified. Four EP receptor subtypes, EP 1 , EP 2 , EP 3 , and EP 4 receptors have also been identified. Activation of the EP 1 receptor increases calcium mobilization. Both EP 2 and EP 4 receptors are coupled with cAMP generation. In addition, splice variants of the EP 3 receptor mediate the activation of several second messengers, leading to changes in cAMP levels, calcium mobilization, and activation of phospholipase C (Narumiya et al., 1999) .
Zymosan, cell wall of the yeast Saccharomyces cerevisiae, has been used extensively as a phagocytic and inflammatory stimulus both in vitro and in vivo. Zymosan is composed primarily of ␤-glucans, mannans, mannoproteins, and chitin, and each of these components has been implicated in recognition of the yeast by the innate immune system (Di Carlo and Fiore, 1958) . Zymosan activates the complement system and plasma kallikrein-kinin system to generate proinflammatory mediators (Damas et al., 1990) . Moreover, zymosan particles are recognized through Toll-like receptor 2 and dectin-1 receptor, resulting in activation of nuclear factor-B and production of inflammatory cytokines and chemokines (Gantner et al., 2003) .
We previously demonstrated that COX-2 and mPGES-1, which are inducible types of enzymes (Helliwell et al., 2004) , were expressed in the draining lymph node and that COX-2 inhibitors enhanced the expression of these enzymes in a carrageenin-induced pleurisy model. Moreover, we suggested that COX-1-and COX-2-derived prostanoids might play differential or sometimes opposing roles in the late phase of acute inflammation (Nakano et al., 2007) . Furthermore, it has been reported that the COX-2/PGE 2 pathway is involved in hepatic abscess formation in the hamster liver induced by intrahepatic inoculation of Entamoeba histolytica trophozoites (Sá nchez-Ramírez et al., 1997 . The objective of the current study was to elucidate the role of prostanoids and their signal transduction pathway in abscess formation. We also examined the mode of action of prostanoids in abscess formation.
Materials and Methods
Zymosan-Induced Pleurisy. All experiments were approved by the institutional review board for animal studies and performed according to the Guideline for Animal Experimentation by Kitasato University (Sagamihara, Japan). Pleurisy was induced in male Sprague-Dawley rats (9 -10 weeks old), purchased from Charles River Japan (Yokohama, Japan), by intrapleural injection of 0.2 ml of zymosan (2%) (lot no. 117H0380; Sigma-Aldrich, St. Louis, MO) under light ether anesthesia. Zymosan was suspended in saline, mixed with a mixer just before aspiration into a syringe, and then immediately injected. At a given time, the rats were euthanized under ether anesthesia. The pleural exudate was harvested and its volume was measured. Abscesses and parathymic lymph nodes were isolated with adjacent tissues. Kidneys were also excised for positive control of polymerase chain reaction (PCR) analysis. The number of intrapleural abscesses was enumerated and their minor diameter (d1), major diameter (d2), and thickness (t) were measured to determine their volumes. The abscess volume was calculated as follows: abscess volume (mm 3 ) ϭ ϫ d1/2 ϫ d2/2 ϫ t/2 ϫ 4/3. For Western blot analysis, abscesses and lymph nodes were cut into small pieces with scissors, and the cells were squeezed with two slide glasses. The cells were filtered with a nylon mesh and washed with buffered saline. The collected cells were stored at Ϫ80°C until analysis after enumeration and centrifugation at 88g for 10 min at room temperature. For PCR analysis, samples were homogenized with TRIzol (Invitrogen, Carlsbad, CA) and stored at Ϫ80°C. For immunohistochemical analysis, the abscesses were fixed with 4% paraformaldehyde, dehydrated, and then paraffin-embedded. Crosssections (2 m in thickness) of paraffin-embedded tissues were mounted on slide glasses. "0 h" samples were obtained from cells of pleural lavage and septal connective tissue, around which abscess would form, of normal control rats.
Western Blot Analysis. Western blot analysis for COX-2 was performed by the method described previously (Nakano et al., 2007) . In brief, the immunoreactive protein was reacted with rabbit antimouse COX-2 antibody (Cayman Chemical, Ann Arbor, MI) and then with goat anti-rabbit IgG conjugated with horseradish peroxidase (Organon Teknika N.V. Cappel Products, Durham, NC) and the enhanced chemiluminescent reagent (GE Healthcare, Little Chalfont, Buckinghamshire, UK). The expression level of COX-2 was semiquantified by a comparison of the luminescence intensity of samples (10 g of protein) and sheep COX-2 protein (100 ng; Cayman Chemical).
Immunohistochemical Analysis. Immunohistochemical analysis was performed by the method described previously (Nakano et al., 2007) . Rabbit antibodies (Cayman Chemical) used were anti-mouse COX-2, anti-human cPGES, anti-human mPGES-1, anti-human mPGES-2, anti-human TXS, anti-murine PGIS, and anti-human EP 2 receptor. Nonimmunized normal rabbit IgG (Dako Denmark A/S, Glostrup, Denmark) was used as negative control. Immunoreactive proteins were detected with horseradish peroxidase-labeled goat anti-rabbit IgG antibody (Nichirei, Tokyo, Japan) and diaminobenzidine (Dako Denmark A/S). Immune reactive EP 2 receptor was detected by tyramide signal amplification (Tsuchiya et al., 2006) . Some cross-sections were stained with hematoxylin-eosin.
Reverse Transcription-PCR Analysis. Frozen homogenate was thawed, and then total RNA was extracted and further purified by DNase-I (Takara, Ohtsu, Japan) as described previously (Nakano et al., 2007) . A PrimeScript reverse-transcription (RT) reagent kit (Takara) was used for synthesis of first-strand cDNA according to the protocol provided by the manufacturer. The resulting cDNA (10 ng of total RNA equivalent) was amplified in a final volume of 25 l containing each primer (final 0.4 M) and 0.625 units of Taq polymerase (Takara). The primers used were as follows: EP 1 receptor, sense 5Ј-GAG AAC GCA GGT CCC GAT G-3Ј, antisense 5Ј-CCA ACA CCA CCA ATA CCA GCA G-3Ј; EP 3 receptor, sense 5Ј-CCT TTG CCT CCG CCT TCG-3Ј, antisense 5Ј-CGA ACG GCG ATT AGG AAG G-3Ј. The primers of DP 1 , EP 2 , EP 4 , IP, and TP receptors and ␤ 2 M were purchased from Takara. PCR amplification was performed using a thermal cycler (GeneAmp PCR System 2400; PerkinElmer Life and Analytical Sciences, Waltham, MA) by initial denaturation at 94°C for 5 min, 35 cycles of denaturation at 94°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 1 min. Amplification products were subjected to electrophoresis on 3% agarose and stained with ethidium bromide. 
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Taq II (Takara) by using Mini Opticon (Bio-Rad, Hercules, CA) according to the protocol provided by the manufacturer. The primer pairs were as follows: cPGES, sense, 5Ј-GGT TAA CAA AGG AAA GGG CAA A-3Ј, antisense, 5Ј-GCG TCA TCC TCC CAG TCT TTC-3Ј; mPGES-2, sense, 5Ј-ACA GCC GTG GGC AAA GA-3Ј, antisense, 5Ј-GTC GCA TCA GGT CGT CAA AG-3Ј. Other primers were purchased from Takara. The level of each mRNA was normalized by that of ␤ 2 M.
Drugs. All drugs were administered twice (8 and 16 h), and their effects were evaluated 24 h after zymosan injection.
Ketorolac [(Ϯ)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid; 1 mg/kg in each administration], a selective COX-1 inhibitor (Warner and Mitchell, 2004) , was purchased from Sigma-Aldrich. N- methanesulfonamide (NS-398; 3 mg/kg in each administration), a selective COX-2 inhibitor (Futaki et al., 1994) , was a generous gift from Taisho Pharmaceutical Co., Ltd. (Tokyo, Japan). These COX inhibitors were suspended in 1% carboxymethyl cellulose and administered orally. The dose of COX inhibitors was chosen according to our previous reports (Harada et al., 1996; Nakano et al., 2007) .
Both 11,15-O-dimethyl PGE 2 (ONO-AE1-259; 1 g in each administration), an EP 2 receptor agonist, and 16-(3-methoxymethyl) phenyl--tetranor-3,7-dithia PGE 1 (ONO-AE1-329; 10 g in each administration), an EP 4 receptor agonist, were generous gifts from Ono Pharmaceutical Co., Ltd. (Osaka, Japan) (Sugimoto and Narumiya, 2007) . Rolipram (4-[3-(cylopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone; 100 g in each administration), a phosphodiesterase type 4 inhibitor (Torphy, 1998) , was purchased from Sigma-Aldrich. ONO-AE1-259 was dissolved in saline. Others were first dissolved in dimethyl sulfoxide (DMSO) and then diluted with saline. The volume of DMSO was 10 l/0.2 ml of saline in each administration. These drugs were injected intrapleurally.
Data Analysis. Results are expressed as mean Ϯ S.E.M. Student's t test was used to determine significant differences between means of two groups. Tukey's multiple comparison test after the one-way analysis of variances or Bonferroni post test after two-way analysis of variances was used for multiple comparisons by using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA). Statistical significance was designated as a p value Ͻ0.05 and was indicated by an asterisk in the figures.
Results

A General Profile of Zymosan-Induced
Pleurisy. An injection of 0.2 ml of zymosan (2%) into the pleural cavity of rats caused an accumulation of inflammatory exudate, which started just after the injection and continued to increase up to 14 h (3.50 Ϯ 0.35 ml, n ϭ 4). Then the exudate volume rapidly decreased until day 2 (Fig. 1A) . The total count of leukocytes in the exudate increased very rapidly until 9 h after zymosan injection and then reached a peak at 24 h (226.5 Ϯ 29.5 cells, n ϭ 6) (Fig. 1B) . Abscess formation started approximately 8 h after zymosan injection (Fig. 1C) . Abscesses formed on the septum and diaphragm and sometimes on the lung or even on the heart. Abscess formation started with fibrination on the surface of the pleural connective tissue and capture of leukocytes into the fibrin. Then the mass of captured cells rapidly increased with time, growing into a visible size (16 -24 h). At this stage, the morphological characteristic of leukocytes in the central part of the abscess became unclear with hematoxylin-eosin staining, seeming to be in apoptosis or necrosis.
By using real-time PCR, mRNA for interleukin (IL)-1␤, IL-6, IL-10, transforming growth factor (TGF)-␤1, connective tissue growth factor (CTGF), and granulocyte colony-stimulating factor (G-CSF) were detected in both abscess and exudate leukocytes (Fig. 2) . Although the mRNA levels were very low or below the detection limit in samples from normal control rats (0 h), the level was dramatically increased by induction of pleurisy. When the mean level of IL-1␤ mRNA during inflammation was expressed as 100%, that of other cytokine mRNA were as follows: 8.1% for TGF-␤1, 0.8% for IL-10, 0.4% for G-CSF, 0.3% for IL-6, and 0.3% for CTGF in exudate leukocytes; and 5.6% for IL-10, 5.5% for IL-6, 2.2% for G-CSF, 1.9% for TGF-␤1, and 0.4% for CTGF in abscesses. Thus, among studied cytokine mRNAs, IL-1␤ mRNA was the most prominent in both locations.
Effects of COX Inhibitors on Abscess Formation. Both NS-398 and ketorolac significantly reduced the volume of pleural exudate (Fig. 3A) , suggesting that these inhibitors work in this model. The inhibitors also slightly but significantly reduced the leukocyte count in the pleural exudate (Fig. 3B) . Although neither of these inhibitors significantly affected the number of abscesses formed (Fig. 3C) , size of abscesses and cell counts recovered from the abscess were significantly decreased by treatment with these COX inhibitors (Fig. 3, D 
and E).
COX-2 Expression. Levels of COX-2 protein in the exudate leukocytes, abscesses, and parathymic lymph nodes were studied by using Western blot analysis (Fig. 4A ). In the exudate cells, COX-2 was detectable and its level reached a peak at 5 h after zymosan injection and then subsided to almost the detection limit. A high level of COX-2 was detectable in the cells collected from abscesses just after the start of their formation. The level continued to increase to a level approximately 4 times higher than the peak level in the exudate cells. Then the level gradually declined. The level of COX-2 in parathymic lymph nodes remained low near the detection limit.
The above findings of expression levels of COX-2 protein in the exudate leukocytes and abscesses were confirmed by using real-time PCR (Fig. 4B) . The mRNA level of COX-2 peaked at 8 h after zymosan injection both in the exudate leukocytes and abscesses. The levels in both locations were almost the same. Expression of COX-2 protein was mainly detected in neutrophils and macrophages in the marginal area of abscesses by immunohistochemistry (Fig. 4C) .
Expression of Terminal PG Synthases. Levels of terminal PG synthases were examined by using real-time PCR (Fig. 5) . Among detected mRNA for terminal PG synthases, cPGES mRNA was dominant in both exudate leukocytes and abscesses. When the mean level of cPGES mRNA during inflammation was expressed as 100%, that of other enzymes were as follows: 72.3% for TXS, 2.1% for PGIS, 1.6% for mPGES-1, 1.4% for mPGES-2, and 1.0% for hPGDS in exudate leukocytes; and 34.3% for TXS, 31.1% for PGIS, 7.6% for mPGES-1, 1.7% for hPGDS, and 1.3% for mPGES-2 in abscesses.
Localization of terminal PG synthases in the abscess was studied by using an immunohistochemical technique (Fig. 6) . Cytosolic PGES was detectable in almost all types of cells in the abscess and surrounding connective tissues, including macrophages, neutrophils, and fibroblasts. Membrane-bound PGES-1 was detected in macrophages and neutrophils in the marginal area of the abscess. Thus, the mPGES-1-positive cells were similar to COX-2-expressing cells in morphology and localization. Membrane-bound PGES-2 was occasionally detected in vascular endothelial cells and macrophages of surrounding connective tissues. PGIS was detected in fibroblasts and macrophages of connective tissues. TXS was detected in macrophages and neutrophils in the marginal area of the abscess. Thus, most of the TXS-positive cells were also morphologically similar to COX-2-expressing cells.
Expression of mRNAs for Prostanoid Receptors. mRNA levels of prostanoid receptors in the exudate leukocytes and abscesses were studied by using RT-PCR (Fig. 7A ). Whereas a very low level of DP 1 receptor was detectable in the draining lymph node, it was below the detection limit in the exudate leukocytes and abscesses. EP 1 and EP 3 receptors were also below the detection limit in the exudate leukocytes and abscesses, whereas they were detected in the kidney. EP 2 and EP 4 receptors were detected in the exudate leukocytes and abscesses. Low levels of IP and TP receptors were also detected in both samples.
The mRNA levels of EP 2 , EP 4 , IP, and TP receptors were semiquantified by using real-time PCR. When the mean level of EP 2 receptor mRNA during inflammation was expressed as 100%, that of other receptors were as follows: 41.1% for IP receptor, 1.6% for EP 4 receptor, and 0.1% for TP receptor in exudate leukocytes; and 3.4% for EP 4 receptor, 2.0% for IP receptor, and 0.1% for TP receptor in abscesses. Thus, EP 2 receptor was the main prostanoid receptor in both exudate leukocytes and abscesses (Fig. 7B) .
Localization of the EP 2 Receptor. By using an immunohistochemical technique, localization of EP 2 receptor-expressing cells was studied in the abscess (Fig. 7C) . EP 2 receptor was detected by using the amplification method, but nonimmunized normal rabbit IgG did not show any appreciable level of staining (data not shown). EP 2 receptor-positive cells were neutrophils and mononuclear leukocytes, and they localized in the marginal area but not in the central area of the abscess. Therefore, EP 2 receptor-positive cells were similar to cells expressing COX-2 and mPGES-1 in morphology and localization.
Recovering Effects of EP Receptor Agonists and Rolipram against the Effects of COX Inhibitors. Because ONO-AE1-329 and rolipram were dissolved in DMSO, the effect of DMSO on abscess formation was studied in a preliminary experiment. However, no significant change in abscess formation was observed (Fig. 8A) . In addition, we have The time points at which the cell counts were significantly higher (p Ͻ 0.05) than that at 0 h were as follows: 9, 14, and 24 h for total leukocytes; 9, 14, and 24 h for neutrophils; 14, 24, and 48 h for mononuclear cells. C, histological analysis with hematoxylin-eosin stain of the abscess at the indicated time points. Scale bars, 200 m (top panels) and 40 m (bottom panels). Similar results were obtained from three additional sets of the rat.
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performed preliminary experiments to determine the dose of EP receptor agonists and rolipram (Fig. 8, B-D) . Their doses were selected as the sufficient doses that would recover the volume of pleural exudate or abscess size reduced by COX inhibitors.
The suppression of pleural exudate accumulation induced by NS-398 was significantly recovered by coadministration of ONO-AE1-259 (1 g in each administration), ONO-AE1-329 (10 g in each administration), or rolipram (100 g in each administration), indicating that these agents work well in this pleurisy model (Fig. 9A, left panel) . The reduction of abscess size induced by NS-398 was significantly recovered by ONO-AE1-259 and rolipram but not by ONO-AE1-329 (Fig. 9A, middle panel) . In addition, the decrease in cell count in the abscess induced by the COX-2 inhibitor was also significantly recovered by ONO-AE1-259 and rolipram but not by ONO-AE1-329 (Fig. 9A, right panel) . In contrast, the reduced leukocyte count in the pleural exudate was only The suppression of pleural exudate accumulation induced by ketorolac was also recovered by coadministration of ONO-AE1-259 (Fig. 9B, left panel) . The reduction of abscess size and the reduction of cell count in the abscess induced by ketorolac were again significantly recovered by ONO-AE1-259 (Fig. 9B, middle and right panels) .
Effects of NS-398 and ONO-AE1-259 on Levels of mRNAs for Cytokines. Effects of NS-398 and ONO-AE1-259 on levels of mRNAs coding for cytokines, IL-1␤, IL-6, IL-10, TGF-␤1, CTGF, and G-CSF, were assessed in exudate leukocytes (Fig. 10) . Levels of these mRNAs, with the exception of IL-10 mRNA, were significantly reduced by treatment with NS-398 and recovered by treatment with a combination of NS-398 and ONO-AE1-259. Although IL-10 mRNA was not significantly affected by administration of NS-398, it was significantly increased by coadministration of NS-398 and ONO-AE1-259.
Discussion
Both zymosan and carrageenin have been widely used as inflammatory stimuli, including in the pleurisy model. A high level of COX-2 expression with remarkable enlargement of parathymic lymph nodes but no abscess formation was observed in the carrageenin-induced pleurisy (Nakano et al., 2007 ). COX-2 expression level in the lymph nodes remained low, whereas abscess formation was observed in the zymosan-induced pleurisy. Moreover, accumulated pleural exudate and leukocytes were less and they subsided more rapidly in the zymosan model than in the carrageenin model (Harada et al., 1996) . Carrageenin is a sulfated polysaccharide isolated from marine algae and is water-soluble (Di Rosa, 1972) . Zymosan is composed of ␤-glucans, mannans, mannoproteins, and chitin and is water-insoluble (Di Carlo and Fiore, 1958) . Both carrageenin and zymosan activate the complement and kallikrein-kinin system (Damas et al., 1990; Ogino et al., 1996) . In addition, carrageenin is recognized by Toll-like receptor 4/MyD88 (Tsuji et al., 2003) . Zymosan is recognized through Toll-like receptor 2 and dectin-1 receptor (Gantner et al., 2003) . These differences in physicochemical properties and their recognition systems may result in the differences in the general profile of inflammatory responses and the presence or absence of abscess formation.
Sá nchez-Ramírez et al. (1997, 2004 ) emphasized the contribution of COX-2 to abscess formation in the hamster liver induced by intrahepatic inoculation of E. histolytica trophozoites. In the present study, both NS-398 and ketorolac suppressed abscess formation, suggesting that prostanoids produced via COX-1 and COX-2 up-regulates abscess formation. In the carrageenin model, ketorolac reversed the effects of NS-398 on COX-2 expression in lymph nodes (Nakano et al., 2007) . All of these results suggest that not only COX-2 products but also COX-1 products may be involved in inflammation. However, the direction of their actions in the two models is different: whereas they exerted recovering effects in lymph nodes in the carrageenin model, both products worked cooperatively in abscess formation in the zymosan model. Gilroy et al. (1998a,b) suggested differential contribution of COX-1-and COX-2-derived prostanoids in models of acute and chronic inflammation. In contrast, COX-1 and COX-2 products act synergistically in healing of ischemia reperfusioninduced gastric lesions (Brzozowski et al., 1999) . These results suggest that both COX-1 and COX-2 products may be involved in inflammation, acting in either a synergistic or opposing manner depending on the circumstances in which they are generated.
Whereas COX-1 is expressed constitutively in most cells, COX-2 expression is low or undetectable in most cells and its expression increases dramatically upon various stimuli. COX-1 is more enriched in the endoplasmic reticulum than in the perinuclear envelope, and COX-2 is located predominantly in the perinuclear envelope (Morita et al., 1995) . Perinuclear terminal synthases, including mPGES-1, PGIS, and TXS, prefer COX-2 to COX-1. Cytosolic PGES is definitively coupled with COX-1. Both COX-1 and COX-2 can be coupled with mPGES-2 (Murakami and Kudo, 2004) . Keeping the above discussion in mind, the major terminal PG synthase was cPGES in both abscesses and exudate leukocytes, suggesting that PGE 2 produced via COX-1 may be the major prostanoid in this model. Furthermore, both mPGES-1 and TXS were detectable in cells that were similar to COX-2-expressing cells in localization and morphology, suggesting that PGE 2 and TXA 2 may be produced via COX-2. mRNAs coding for EP 2 , EP 4 , IP, and TP receptors were detectable in the exudate leukocytes and abscess. Those for DP 1 , EP 1 , and EP 3 receptor were below the detection limits. DP 2 and FP receptor were not used to detect. Among the detected prostanoid receptors, EP 2 receptor was the most prominent in both locations. Furthermore, the inhibition of abscess formation induced by COX inhibitors was reversed by the EP 2 receptor agonist but not by the EP 4 receptor agonist, even though both agonists reversed the reduced exudate volume. Furthermore, rolipram, which is a phosphodiesterase type-4 inhibitor (Torphy, 1998) , also reversed the inhibitory effect of NS-398 on abscess formation. Phosphodiesterase type-4 is functionally most important for regulation of a level of cAMP in leukocytes (Torphy, 1998) . Although, phosphodiesterase type-4 inhibitors are currently being eval- jpet.aspetjournals.org uated as potential therapeutics for inflammatory diseases, they also possess proinflammatory activities depending on the circumstances in which they are applied (Soares et al., 2003; McCluskie et al., 2006) . Thus, the present study suggests that the prostanoid receptor involved in abscess formation may be coupled with G proteins, which stimulates adenylate cyclase and thus increases the intracellular cAMP level. Among prostanoid receptors, DP 1 , EP 2 , EP 4 , and IP receptors are coupled with Gs proteins (Narumiya et al., 1999) . All of these results suggest that PGE 2 mediated by the EP 2 receptor/adenylate cyclase pathway may be involved in abscess formation.
It has been suggested that TXA 2 produced via COX-2 is involved in migration of endothelial cells and angiogenesis (Daniel et al., 1999) . Whereas a substantial amount of TXS was detected in cells that were similar to COX-2-expressing cells in localization and morphology, the mRNA level of TP receptor was very low. Furthermore, angiogenesis was not prominent until 24 h after irritation (data not shown). Therefore, it is plausible that TXA 2 is involved in angiogenesis in a later phase than that studied here. Rajakariar et al. (2007) proposed that hPGDS and DP 1 receptor control the onset and resolution of zymosan-induced peritonitis through PGD 2 and 15-deoxy⌬ 12-14 PGJ 2 from the results of a study using hPGDS-deficient mice with a selective DP 1 receptor agonist. However, the localization of hPGDS and DP 1 receptor were not determined in their study. In the present study, a low level of hPGDS was detected in the abscess and exudate cells, but the mRNA level of DP 1 receptor was below the detection limit in these locations. A low level of DP 1 receptor mRNA was detected in the draining lymph node instead. Therefore, our results also suggest some contribution of the PGD 2 /DP 1 receptor pathway in the later phase of inflammation.
Some authors have suggested contribution of the PGI 2 /IP receptor pathway in inflammatory models (Hatanaka et al., 1999; Pulichino et al., 2006) . In the present study, mRNA levels of PGIS and IP receptor were lower than those of cPGES and EP 2 receptor in both abscesses and exudate leukocytes, respectively. In addition, it is well known that PGI 2 is chemically less stable than PGE 2 and degrades in a short time into biologically inactive 6-keto-PGF 1 ␣. Thus, contribution of the PGI 2 /IP receptor pathway may not exceed that of the PGE 2 /EP 2 receptor pathway in abscess formation.
EP 2 receptor mRNA and a lower level of EP 4 receptor mRNA were detected in the abscesses and exudate leukocytes. In addition, the levels of IP and TP receptors were very low. Levels of DP 1 , EP 1 , and EP 3 receptor were below the detection limit. Thus, among prostanoid/receptor pathways, the PGE 2 /EP 2 receptor pathway may be the major one acting in the abscess and exudate cells. Moreover, EP 2 receptor-positive cells were similar to COX-2-and mPGES-1-expressing cells in morphology and localization as well as time course. These results suggest that PGE 2 produced via COX-2/mPGES-1 may act on EP 2 receptor in an autocrine manner. PGE 2 produced via COX-1/cPGES may also act on abscess formation. It is well known that prostanoids regulate numerous cell functions, including cytokine production. PGE 2 stimulates IL-1␤ expression in macrophages through activation of adenylate cyclase (Ohmori et al., 1990) . Furthermore, PGE 2 accelerates release of IL-6, IL-10, and G-CSF from neutrophils and macrophages via EP 2 and EP 4 receptors (Yamane et al., 2000; Treffkorn et al., 2004; Sugimoto et al., 2005) . In this study, we showed that NS-398 significantly decreased mRNA levels of IL-1␤, IL-6, and G-CSF in the exudate leukocytes and that the EP 2 receptor agonist reversed the effect of NS-398 on the cytokine mRNA levels. The level of IL-10 mRNA was not significantly affected by NS-398, but it was significantly increased by the EP 2 receptor agonist. IL-1␤ is the representative proinflammatory cytokine and induces neutrophil migration into the site of inflammation (Oliveira et al., 2008) . IL-6 is a multifunctional cytokine that plays a central 9 . Recovering effects of EP receptor agonists and rolipram against the effects of COX inhibitors. All drugs were administered twice (8 and 16 h), and their effects were evaluated 24 h after zymosan injection. A, effects of ONO-AE1-259 (AE1-259; 1 g in each intrapleural administration), ONO-AE1-329 (AE1-329; 10 g in each intrapleural administration), and rolipram (100 g in each intrapleural administration) against the effects of NS-398 (3 mg/kg in each oral administration). Each value is the mean Ϯ S.E.M. of 5 to 15 rats. B, effects of ONO-AE1-259 against the effects of ketorolac (1 mg/kg in each oral administration). Each value is the mean Ϯ S.E.M. of 6 to 8 rats. Asterisks indicate statistically significant differences of means (p Ͻ 0.05). Fig. 10 . Recovering effects of the EP 2 receptor agonist against the effect of the COX-2 inhibitor on cytokine mRNA levels in exudate leukocytes. NS-398 (3 mg/kg in each oral administration) and ONO-AE1-259 (AE1-259; 1 g in each intrapleural administration) were administered twice (8 and 16 h), and their effects were evaluated 24 h after zymosan injection. Each value is the mean Ϯ S.E.M. of 5 to 10 rats. Asterisks indicate statistically significant differences of means (p Ͻ 0.05).
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at ASPET Journals on April 7, 2017 jpet.aspetjournals.org role in immune responses. It regulates the leukocyte recruitment transition from neutrophil to mononuclear cell infiltrate in acute inflammation. It also stimulates proliferation of fibroblasts and increases collagen and glycosaminoglycan synthesis (Kaplanski et al., 2003) . G-CSF regulates the production and maturation of neutrophils. It also stimulates the survival of mature neutrophils (Gregory et al., 2007) . These proinflammatory activities of IL-1␤, IL-6, and G-CSF may contribute to abscess formation. The predominant role of IL-10 is to reduce inflammation. However, increased expression of IL-10 significantly contributes to fibrosis (Bergeron et al., 2003; Barbarin et al., 2005) . The present study also showed that treatment with NS-398 significantly decreased mRNA levels of TGF-␤1 and CTGF, which was again reversed by the EP 2 receptor agonist. CTGF is a cytokine induced by TGF-␤ and is thought to play a critical role in TGF-␤-stimulated proliferation of fibroblasts and extracellular matrix accumulation (Shi-Wen et al., 2008) . These activities of TGF-␤ and CTGF may also accelerate abscess formation.
In conclusion, the present study suggests that the PGE 2 /EP 2 receptor pathway may play a role in promotion of abscess formation by stimulating production of proinflammatory and fibrogenic cytokines in both direct and indirect manners.
